Public Calendar: May 17-23, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
No Significant Event
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
Event Date: 05/21/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders
Event Date: 05/21/2020
Location: Virtual
Subject: UCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) Scientific Advisory Board Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Represenatives from industry, academia, and other stakeholders
Event Date: 05/22/2020
Location: Virtual
Subject: Vaccines and Data for COVID-19
FDA Participant/Group: MIMI NGUYEN; LORRIE MCNEILL; LAURA CALIGUIRI; EMILY HELMS WILLIAMS; PETER MARKS; JULIA TIERNEY; STEVE MORIN; GINA VALO; DAYLE CRISTINZIO; SARAH LYNCH; COLIN ROM; JOSEPH FRANKLIN;
Non FDA Participant/Group: Rob Lenz (Amgen); James Mayne, Kelly Goldberg, Lucy Vereshchagina, Mary Kosinski, Richard Moscicki (PhRMA); Liz Roberts (UCB); J.R. Meloro (Pfizer); Eddie Reilly (Sanofi); John Tsai (Novartis); Mathai Mammen (Janssen/J&J); Annetta Beauregard (Johnson & Johnson); Tim Montague (GSK); Carl Garner (Eli Lilly); Anne Heatherington (Takeda);
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 05/20/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: KARI BARRETT; SUSAN MAYNE; MARK MOORMAN;
Non FDA Participant/Group: Several executives from the food industry
Event Date: 05/20/2020
Location: Virtual
Subject: Leafy Greens Investigation Report
FDA Participant/Group: N/A
Non FDA Participant/Group: Rep. Jimmy Panetta (D-CA);
Event Date: 05/21/2020
Location: Virtual
Subject: United States-Canada Joint Committee on Food Safety
FDA Participant/Group: Several FDA staff members
Non FDA Participant/Group: Several executives and staff from Health Canada and Canadian Food Inspection Agency
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event